A Necessary Caution GLP-1 medications carry risks as well as benefits
GLP-1 drug warnings and studies include: FDA label updates for Ozempic: The new label change in January 2025 warns that Ozempic is associated with gastrointestinal adverse reactions, sometimes severe. However, it does not specifically say Ozempic causes gastroparesis, also known as stomach paralysis
This trend will challenge employers, health plans and drug manufacturers to balance access and affordability without compromising clinical support and oversight to patients when medications are covered by insurance. The poll findings echo Navitus most recent Drug Trend Report, which cited growth of GLP-1s, especially higher-cost, brand-name products, as one of the biggest drivers of overall drug utilization and cost
Calibrate combines GLP-1 medication, like Wegovy and Saxenda, with lifestyle changes to help you lose 15% of your body weight on average
Our licensed providers offer personalized care to support your wellness and beauty goals
)
